Reuters logo
BRIEF-Nuvo Pharmaceuticals reports Q3 loss per share of C$0.02 from continuing operations
November 1, 2017 / 10:08 PM / 23 days ago

BRIEF-Nuvo Pharmaceuticals reports Q3 loss per share of C$0.02 from continuing operations

Nov 1 (Reuters) - Nuvo Pharmaceuticals Inc

* Nuvo Pharmaceuticals announces 2017 third quarter results

* Q3 loss per share C$0.02 from continuing operations

* Q3 revenue C$3.0 million versus C$5.5 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below